Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)

B. D. Cheson; N. L. Bartlett; J. M. Vose; A. Lopez-Hernandez; A. L. Seiz; A. T. Keating; S. Shamsili; K. P. Papadopoulos; Kyriakos P. Papadopoulos

doi:10.1002/cncr.27384

Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)

B. D. Cheson, N. L. Bartlett, J. M. Vose, A. Lopez-Hernandez, A. L. Seiz, A. T. Keating, S. Shamsili, K. P. Papadopoulos, Kyriakos P. Papadopoulos

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	4365
Number of pages	1
Journal	Cancer
Volume	118
Issue number	17
DOIs	https://doi.org/10.1002/cncr.27384
State	Published - Sep 1 2012
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.27384

Cite this

@article{4b0cba9ae0a34d6f81760999cc609e7f,

title = "Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)",

author = "Cheson, {B. D.} and Bartlett, {N. L.} and Vose, {J. M.} and A. Lopez-Hernandez and Seiz, {A. L.} and Keating, {A. T.} and S. Shamsili and Papadopoulos, {K. P.} and Papadopoulos, {Kyriakos P.}",

year = "2012",

month = sep,

day = "1",

doi = "10.1002/cncr.27384",

language = "English (US)",

volume = "118",

pages = "4365",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "17",

}

TY - JOUR

T1 - Erratum

T2 - A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)

AU - Cheson, B. D.

AU - Bartlett, N. L.

AU - Vose, J. M.

AU - Lopez-Hernandez, A.

AU - Seiz, A. L.

AU - Keating, A. T.

AU - Shamsili, S.

AU - Papadopoulos, K. P.

AU - Papadopoulos, Kyriakos P.

PY - 2012/9/1

Y1 - 2012/9/1

UR - http://www.scopus.com/inward/record.url?scp=84865332727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865332727&partnerID=8YFLogxK

U2 - 10.1002/cncr.27384

DO - 10.1002/cncr.27384

M3 - Comment/debate

AN - SCOPUS:84865332727

SN - 0008-543X

VL - 118

SP - 4365

JO - Cancer

JF - Cancer

IS - 17

ER -

Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this